Last update 12 Dec 2024

SYHA-1813

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SYHA 1813, SYHA1813
Mechanism
CSF-1R antagonists(Colony stimulating factor 1 receptor antagonists), VEGFR antagonists(Vascular endothelial growth factor receptor antagonists)
Active Indication
Inactive Indication-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MeningiomaPhase 2
CN
11 Dec 2024
Solid tumorPhase 2
CN
14 Nov 2024
GliosarcomaPhase 1
CN
20 Dec 2023
Brain metastasesPhase 1
CN
26 May 2021
Colorectal CancerPhase 1
CN
26 May 2021
Giant Cell Tumor of Tendon SheathPhase 1
CN
26 May 2021
High grade gliomaPhase 1
CN
26 May 2021
Kidney NeoplasmsPhase 1
CN
26 May 2021
Lung CancerPhase 1
CN
26 May 2021
Stomach CancerPhase 1
CN
26 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
38
gywlqmypuc(bszevnoute) = TRAEs ≥ grade 3 occurred in more than 2 patients were hypertension (28.9%) and decreased platelet count (10.5%) ywcnbvzvzz (xhlnxvjpwh )
Positive
15 Sep 2024
SYHA1813 15mg
Phase 1
11
jmsuihauwp(zhawgjvive) = aoqqpyungm palycqnnai (weqldsdqyf, 16.8 - 76.6)
Positive
21 Oct 2023
Phase 1
14
nfmwottdge(sqnxpebxcv) = zxnuvbbkdd zstcbuddjd (mvnublwvjb )
-
08 Mar 2023
Phase 1
14
icvnycfqwd(blynxshqdn) = The dose-limiting toxicities (DLTs) were grade (G) 4 hypertension (n = 1) and G3 mucositis oral (n =1) at 30 mg. gzrbtlovpb (gtzbhzibcg )
Positive
10 Sep 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free